Abstract 3535: Differential expression and localization of the E3 ubiquitin ligase Nrdp1 in African American versus Caucasian American prostate cancer cells

Author(s):  
Neelu Batra ◽  
Sheryl Krig ◽  
Anhao Sam ◽  
Katelyn Macias ◽  
Rosalinda Savoy ◽  
...  
2017 ◽  
Author(s):  
Gatikrushna Panigrahi ◽  
Taylor C. Peak ◽  
Sierra L. Patterson ◽  
Nicole Kasica ◽  
Ravi Singh ◽  
...  

2008 ◽  
Vol 40 (Supplement) ◽  
pp. S289 ◽  
Author(s):  
Vernon Bond ◽  
Rajagopalan Sridhar ◽  
Alemayehu Kassa ◽  
Raymond Blakely ◽  
Rachel Austin ◽  
...  

2018 ◽  
Author(s):  
Gati Panigrahi ◽  
Prakash Praharaj ◽  
Kiran Sai ◽  
Gargi Mahapatra ◽  
Taylor Peak ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 989
Author(s):  
Priyatham Gorjala ◽  
Rick A. Kittles ◽  
Oscar B. Goodman Jr. ◽  
Ranjana Mitra

Androgen receptor signaling is crucial for prostate cancer growth and is positively regulated in part by intratumoral CYP3A5. As African American (AA) men often carry the wild type CYP3A5 and express high levels of CYP3A5 protein, we blocked the wild type CYP3A5 in AA origin prostate cancer cells and tested its effect on androgen receptor signaling. q-PCR based profiler assay identified several AR regulated genes known to regulate AR nuclear translocation, cell cycle progression, and cell growth. CYP3A5 processes several commonly prescribed drugs and many of these are CYP3A5 inducers or inhibitors. In this study, we test the effect of these commonly prescribed CYP3A5 inducers/inhibitors on AR signaling. The results show that the CYP3A5 inducers promoted AR nuclear translocation, downstream signaling, and cell growth, whereas CYP3A5 inhibitors abrogated them. The observed changes in AR activity is specific to alterations in CYP3A5 activity as the effects are reduced in the CYP3A5 knockout background. Both the inducers tested demonstrated increased cell growth of prostate cancer cells, whereas the inhibitors showed reduced cell growth. Further, characterization and utilization of the observation that CYP3A5 inducers and inhibitors alter AR signaling may provide guidance to physicians prescribing CYP3A5 modulating drugs to treat comorbidities in elderly patients undergoing ADT, particularly AA.


2016 ◽  
Vol 11 (1) ◽  
pp. 92-98 ◽  
Author(s):  
Rajagopalan Sridhar ◽  
Vernon Bond ◽  
Jacquelyn Dunmore-Griffith ◽  
Valerie M. Cousins ◽  
Renshu Zhang ◽  
...  

The growth of prostate tumors is mediated by the bioavailability of androgens and insulin-like growth factors. This study tested the hypothesis that healthy young adult African American men exhibiting low aerobic capacity (fitness) have serum insulin-like growth Factor-1 (IGF-1) and testosterone levels that promote growth of prostate cancer cells. A cross-sectional data research design was used to study groups of 18- to 26-year-old healthy men exhibiting low and moderate aerobic fitness, based on their peak oxygen consumption (VO2peak). The individual serum levels of IGF-1, IGF-1 binding protein-3 (IGFBP-3), and testosterone were measured. In vitro growth of androgen-dependent LNCaP prostate tumor cells was measured after incubation in culture medium fortified with each subject’s serum. Aerobic capacity was significantly greater in the moderate-fitness group than in the low-fitness group without an intergroup difference in body mass index. The serum IGF-1 concentration was significantly higher in the low-fitness group in the absence of an intergroup difference in serum testosterone. The serum IGFBP-3 concentration was significantly lower in the low-fitness group. Prostate tumor cell growth was significantly greater in the cultures incubated in media containing the sera of the low-fitness group than in the sera of the moderate-fitness group. These findings suggest that moderate aerobic fitness in young adults may decrease the circulating levels of free IGF-1 and lower the potential to support growth of prostate cancer cells.


Sign in / Sign up

Export Citation Format

Share Document